These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16040085)

  • 61. Evaluation of concordance of Gleason score between prostatectomy and biopsies that show more than two different Gleason scores in positive cores.
    Park HK; Choe G; Byun SS; Lee HW; Lee SE; Lee E
    Urology; 2006 Jan; 67(1):110-4. PubMed ID: 16413344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
    Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
    J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy.
    Algaba F; Arce Y; Oliver A; Barandica C; Santaularia JM; Montañés R
    Eur Urol; 2005 Oct; 48(4):566-71. PubMed ID: 16084008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of prostate biopsy schemes in accurate prediction of Gleason scores.
    Mian BM; Lehr DJ; Moore CK; Fisher HA; Kaufman RP; Ross JS; Jennings TA; Nazeer T
    Urology; 2006 Feb; 67(2):379-83. PubMed ID: 16461089
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
    Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
    J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.
    Rajinikanth A; Manoharan M; Soloway CT; Civantos FJ; Soloway MS
    Urology; 2008 Jul; 72(1):177-82. PubMed ID: 18279938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of percent Gleason grade 4/5 by multiple core biopsies.
    Glaessgen A; Busch C; Norberg M; Häggman M; Nilsson B; Egevad L
    Scand J Urol Nephrol; 2006; 40(6):465-71. PubMed ID: 17130098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
    Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
    Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
    Whitman EJ; Groskopf J; Ali A; Chen Y; Blase A; Furusato B; Petrovics G; Ibrahim M; Elsamanoudi S; Cullen J; Sesterhenn IA; Brassell S; Rittenhouse H; Srivastava S; McLeod DG
    J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade.
    King CR; McNeal JE; Gill H; Brooks JD; Srinivas S; Presti JC
    Urology; 2006 Jun; 67(6):1229-34. PubMed ID: 16765184
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Can pT0 stage of prostate cancer be predicted before radical prostatectomy?
    Descazeaud A; Zerbib M; Flam T; Vieillefond A; Debré B; Peyromaure M
    Eur Urol; 2006 Dec; 50(6):1248-52; discussion 1253. PubMed ID: 16828964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
    Chun FK; Briganti A; Shariat SF; Graefen M; Montorsi F; Erbersdobler A; Steuber T; Salonia A; Currlin E; Scattoni V; Friedrich MG; Schlomm T; Haese A; Michl U; Colombo R; Heinzer H; Valiquette L; Rigatti P; Roehrborn CG; Huland H; Karakiewicz PI
    BJU Int; 2006 Aug; 98(2):329-34. PubMed ID: 16879673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
    Patel DA; Presti JC; McNeal JE; Gill H; Brooks JD; King CR
    J Clin Oncol; 2005 Sep; 23(25):6157-62. PubMed ID: 16135482
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of cancers detected at only a sextant or alternative location.
    Ochiai A; Troncoso P; Babaian RJ
    BJU Int; 2008 Apr; 101(7):837-40. PubMed ID: 18070187
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.
    Montironi R; Mazzuccheli R; Scarpelli M; Lopez-Beltran A; Fellegara G; Algaba F
    BJU Int; 2005 Jun; 95(8):1146-52. PubMed ID: 15877724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.